{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:08:45Z","timestamp":1793225325317,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.autrev.2025.103924","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:57:20Z","timestamp":1762617440000},"page":"103924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Drug- and vaccine induced ANCA-associated vasculitis: An overview"],"prefix":"10.1016","volume":"25","author":[{"given":"Jan Willem","family":"Cohen Tervaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2025.103924_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international chapel hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103924_bb0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1471-1842.2009.00848.x","article-title":"A typology of reviews: an analysis of 14 review types and associated methodologies","author":"Grant","year":"2009","journal-title":"Health Info Libr J"},{"issue":"12","key":"10.1016\/j.autrev.2025.103924_bb0015","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1089\/thy.2014.0603","article-title":"Antineutrophil cytoplasmic antibody-positive small-vessel Vasculitis associated with Antithyroid drug therapy: how significant is the clinical problem?","volume":"25","author":"Balavoine","year":"2015","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.autrev.2025.103924_bb0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12016-012-8320-4","article-title":"Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up?","volume":"43","author":"Cohen Tervaert","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2025.103924_bb0025","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.1780330829","article-title":"Association of autoantibodies to myeloperoxidase with different forms of vasculitis","volume":"33","author":"Cohen Tervaert","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.autrev.2025.103924_bb0030","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178813","article-title":"Sequential carbonyl derivatives and hydrazone adduct formation on myeloperoxidase contribute to development of ANCA vasculitis","volume":"135","author":"Xi","year":"2025","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2025.103924_bb0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/art.20927","article-title":"Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a long-term follow-up study","volume":"53","author":"Slot","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2025.103924_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041289","article-title":"Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case\/non-case approach","volume":"7","author":"de Jong","year":"2012","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.autrev.2025.103924_bb0045","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/art.41902","article-title":"A worldwide Pharmacoepidemiologic update on drug-induced Antineutrophil cytoplasmic antibody-associated vasculitis in the era of targeted therapies","volume":"74","author":"Deshayes","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103924_bb0050","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/bcp.15037","article-title":"Adverse reactions with levamisole vary according to its indications and misuse: a systematic pharmacovigilance study","volume":"88","author":"Campillo","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103924_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103287","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (ASIA) in 2023","volume":"22","author":"Cohen Tervaert","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103924_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109656","article-title":"Increase in the number of new cases of ANCA-associated vasculitis in the COVID-19 vaccine era","volume":"252","author":"Sato","year":"2023","journal-title":"Clin Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2025.103924_bb0065","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s10067-023-06694-6","article-title":"New-onset systemic vasculitis following SARS-CoV-2 infection and vaccination: the trigger, phenotype, and outcome","volume":"42","author":"Mv","year":"2023","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2025.103924_bb0070","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/vaccines12060656","article-title":"ANCA-positive small-vessel vasculitis following SARS-CoV-2 vaccination-a systematic review","volume":"12","author":"\u0141ysak","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.autrev.2025.103924_bb0075","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10067-015-3073-0","article-title":"Viral RNA in the influenza vaccine may have contributed to the development of ANCA-associated vasculitis in a patient following immunization","volume":"35","author":"Jeffs","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2025.103924_bb0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fimmu.2018.00315","article-title":"Checks and balances in autoimmune vasculitis","volume":"9","author":"Hid Cadena","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103924_bb0085","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ndt\/gfy406","article-title":"Should proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibody vasculitis be treated differently: part 2","volume":"34","author":"Cohen Tervaert","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.autrev.2025.103924_bb0090","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/art.40372","article-title":"Brief report: drugs implicated in systemic autoimmunity modulate neutrophil extracellular trap formation","volume":"70","author":"Irizarry-Caro","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"17","key":"10.1016\/j.autrev.2025.103924_bb0095","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015328","article-title":"A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"98","author":"Watanabe-Kusunoki","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.autrev.2025.103924_bb0100","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89780","article-title":"A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity","volume":"2","author":"Carmona-Rivera","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.autrev.2025.103924_bb0105","first-page":"638","article-title":"Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity","volume":"56","author":"Lood","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.autrev.2025.103924_bb0110","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1002\/art.34619","article-title":"Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Nakazawa","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2025.103924_bb0115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.clim.2006.09.011","article-title":"Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis","volume":"122","author":"Zhang","year":"2007","journal-title":"Clin Immunol"},{"issue":"5186","key":"10.1016\/j.autrev.2025.103924_bb0120","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.7973636","article-title":"Rubin RL transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils","volume":"266","author":"Jiang","year":"1994","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.autrev.2025.103924_bb0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/tcrm.1.2.125.62913","article-title":"The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction?","volume":"1","author":"McDanel","year":"2005","journal-title":"Ther Clin Risk Manag"},{"issue":"9","key":"10.1016\/j.autrev.2025.103924_bb0130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0167-5699(93)90244-F","article-title":"Defining criteria for autoimmune diseases (Witebsky\u2019s postulates revisited)","volume":"14","author":"Rose","year":"1993","journal-title":"Immunol Today"},{"issue":"5","key":"10.1016\/j.autrev.2025.103924_bb0135","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/j.1523-1755.2004.05412.x","article-title":"Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?","volume":"65","author":"Heeringa","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2025.103924_bb0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12982-015-0037-4","article-title":"Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology","volume":"12","author":"Fedak","year":"2015","journal-title":"Emerg Themes Epidemiol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103924_bb0145","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40264-022-01155-6","article-title":"Machine learning in causal inference: application in pharmacovigilance","volume":"45","author":"Zhao","year":"2022","journal-title":"Drug Saf"},{"issue":"8","key":"10.1016\/j.autrev.2025.103924_bb0150","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s40264-014-0204-5","article-title":"Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank","volume":"37","author":"Caster","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.autrev.2025.103924_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-210970","article-title":"Levamisole-contaminated cocaine: a hairy affair","volume":"2015","author":"van der Veer","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.autrev.2025.103924_bb0160","series-title":"Drug-induced and iatrogenic respiratory disease","first-page":"308","article-title":"Vasculitis induced by drugs","author":"De Vries","year":"2010"},{"issue":"11","key":"10.1016\/j.autrev.2025.103924_bb0165","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11926-022-01088-0","article-title":"A spotlight on drug-induced vasculitis","volume":"24","author":"Yaseen","year":"2022","journal-title":"Curr Rheumatol Rep"},{"issue":"8872","key":"10.1016\/j.autrev.2025.103924_bb0170","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(93)91761-A","article-title":"Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy","volume":"342","author":"Dolman","year":"1993","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.autrev.2025.103924_bb0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/ard.52.2.115","article-title":"Occurrence of autoantibodies to human leucocyte elastase in Wegener\u2019s granulomatosis and other inflammatory disorders","volume":"52","author":"Cohen Tervaert","year":"1993","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2025.103924_bb0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9440(10)62952-5","article-title":"Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha","volume":"167","author":"Huugen","year":"2005","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103924_bb0185","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2013111233","article-title":"ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease","volume":"26","author":"Kemna","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2025.103924_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/art.43360","article-title":"Trimethoprim\/sulfamethoxazole in clinical trials for granulomatosis with Polyangiitis","author":"Cohen Tervaert","year":"2025","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103924_bb0195","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kead319","article-title":"Characteristics and outcome of ANCA-associated vasculitides induced by anti-thyroid drugs: a multicenter retrospective case-control study","volume":"63","author":"Culerrier","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2025.103924_bb0200","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ehf2.12421","article-title":"Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross-European survey","volume":"6","author":"Brewster","year":"2019","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.autrev.2025.103924_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-196701000-00001","article-title":"Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus","volume":"46","author":"Alarc\u00f3n-Segovia","year":"1967","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2025.103924_bb0210","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-227161","article-title":"Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome","volume":"2018","author":"Aeddula","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.autrev.2025.103924_bb0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2796.1991.tb00342.x","article-title":"Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment","volume":"229","author":"N\u00e4ssberger","year":"1991","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.autrev.2025.103924_bb0220","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.kint.2021.03.029","article-title":"Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine","volume":"100","author":"Santoriello","year":"2021","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.autrev.2025.103924_bb0225","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/01913123.2024.2346660","article-title":"Hydralazine use can be associated with IgM-dominated immune complex-mediated glomerulonephritis","volume":"48","author":"Zhang","year":"2024","journal-title":"Ultrastruct Pathol"},{"issue":"3","key":"10.1016\/j.autrev.2025.103924_bb0230","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/s10165-009-0168-y","article-title":"Hydralazine-induced autoimmune disease: comparison to idiopathic lupus and ANCA-positive vasculitis","volume":"19","author":"Yokogawa","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103924_bb0235","doi-asserted-by":"crossref","first-page":"300","DOI":"10.46497\/ArchRheumatol.2022.9049","article-title":"Vasculitis induced by biological agents used in rheumatology practice: a systematic review","volume":"37","author":"da Silva Cendon Duran","year":"2021","journal-title":"Arch Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2025.103924_bb0240","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2215\/CJN.02181205","article-title":"TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations","volume":"1","author":"Huugen","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.autrev.2025.103924_bb0245","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13317-020-00147-9","article-title":"Sustained clinical remission under infliximab\/rituximab combination therapy in a patient with granulomatosis with polyangiitis","volume":"12","author":"Valor-M\u00e9ndez","year":"2021","journal-title":"Autoimmun Highlights"},{"issue":"6","key":"10.1016\/j.autrev.2025.103924_bb0250","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11926-012-0290-2","article-title":"TNF-\u03b1 blocker therapy and solid malignancy risk in ANCA-associated vasculitis","volume":"14","author":"Silva","year":"2012","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"10.1016\/j.autrev.2025.103924_bb0255","article-title":"Tofacitinib-induced antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis with crescentic glomerulonephritis","volume":"13","author":"Asemota","year":"2021","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.autrev.2025.103924_bb0260","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/rheumatology\/kew063","article-title":"Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition","volume":"55","author":"van den Brom","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.autrev.2025.103924_bb0265","first-page":"1164","article-title":"Adverse Events Associated with Immune Checkpoint Blockade","volume":"378","author":"Cohen Tervaert","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2025.103924_bb0270","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s40674-019-00131-z","article-title":"Immune checkpoint inhibitor associated rheumatic adverse events: a review of their presentations and treatments","volume":"5","author":"Ye","year":"2019","journal-title":"Curr Treat Options Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103924_bb0275","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/rheumatology\/kes034","article-title":"Aberrant expression of the negative costimulator PD-1 on T cells in granulomatosis with polyangiitis","volume":"51","author":"Wilde","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2025.103924_bb0280","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02714432","article-title":"Systemic necrotizing angiitis with asthma: causes and precipitating factors in 43 cases","volume":"165","author":"Guillevin","year":"1987","journal-title":"Lung"},{"key":"10.1016\/j.autrev.2025.103924_bb0285","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/1752-1947-4-188","article-title":"Churg-Strauss syndrome following cessation of allergic desensitization vaccination: a case report","volume":"4","author":"Masjedi","year":"2010","journal-title":"J Med Case Reports"},{"issue":"5","key":"10.1016\/j.autrev.2025.103924_bb0290","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/vaccines10050716","article-title":"New onset of eosinophilic granulomatosis with polyangiitis following mRNA-based COVID-19 vaccine","volume":"10","author":"Nappi","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.autrev.2025.103924_bb0295","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1067\/mai.2001.117176","article-title":"The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report","volume":"108","author":"Weller","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2025.103924_bb0300","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1378\/chest.08-2990","article-title":"Churg-Strauss syndrome in patients treated with omalizumab","volume":"136","author":"Wechsler","year":"2009","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.autrev.2025.103924_bb0305","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2169\/internalmedicine.7990-21","article-title":"Severe asthma where eosinophilic granulomatosis with polyangiitis became apparent after the discontinuation of dupilumab","volume":"61","author":"Ikeda","year":"2022","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.autrev.2025.103924_bb0310","doi-asserted-by":"crossref","first-page":"165","DOI":"10.18176\/jiaci.0823","article-title":"Eosinophilia induced by blocking the IL-4\/IL-13 pathway: potential mechanisms and clinical outcomes","volume":"32","author":"Olaguibel","year":"2022","journal-title":"J Invest Allergol Clin Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2025.103924_bb0315","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.jaip.2020.04.006","article-title":"Eosinophilic granulomatosis with polyangiitis evolution during severe eosinophilic asthma treatment with benralizumab","volume":"8","author":"Ho\u010devar","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.autrev.2025.103924_bb0320","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/all.15934","article-title":"Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: report from the European EGPA study group","volume":"79","author":"Caminati","year":"2024","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.autrev.2025.103924_bb0325","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/mrcr\/rxab010","article-title":"A case of eosinophilic granulomatosis with polyangiitis after prolonged intervals of an anti-interleukin-6 receptor antibody for rheumatoid arthritis","volume":"6","author":"Imai","year":"2022","journal-title":"Mod Rheumatol Case Rep"},{"issue":"19","key":"10.1016\/j.autrev.2025.103924_bb0330","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1056\/NEJM197011052831901","article-title":"Necrotizing angiitis associated with drug abuse","volume":"283","author":"Citron","year":"1970","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2025.103924_bb0335","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/BOR.0000000000000766","article-title":"Cerebral vasculitis associated with drug abuse","volume":"33","author":"Younger","year":"2021","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103924_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102618","article-title":"International consensus on ANCA testing beyond systemic vasculitis","volume":"19","author":"Moiseev","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2025.103924_bb0350","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s00204-017-1947-4","article-title":"Adverse effects of levamisole in cocaine users: a review and risk assessment","volume":"91","author":"Brunt","year":"2017","journal-title":"Arch Toxicol"},{"issue":"4","key":"10.1016\/j.autrev.2025.103924_bb0355","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.autrev.2012.08.009","article-title":"Cocaine-induced midline destructive lesions - an autoimmune disease?","volume":"12","author":"Trimarchi","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2025.103924_bb0360","article-title":"Urine toxicology screening reduces misdiagnosis of cocaine-induced ANCA-positive disease as idiopathic granulomatosis with polyangiitis","volume":"9","author":"Bateman","year":"2025","journal-title":"Rheumatol Adv Pract"},{"issue":"2","key":"10.1016\/j.autrev.2025.103924_bb0365","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00007691-200404000-00020","article-title":"Detection times of drugs of abuse in blood, urine, and oral fluid","volume":"26","author":"Verstrate","year":"2004","journal-title":"Ther Drug Monit"},{"issue":"1\u20133","key":"10.1016\/j.autrev.2025.103924_bb0370","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.forsciint.2009.04.004","article-title":"Pharmacokinetics of disappearance of cocaine from hair after discontinuation of drug use","volume":"189","author":"Garcia-Bournissen","year":"2009","journal-title":"Forensic Sci Int"},{"issue":"9442","key":"10.1016\/j.autrev.2025.103924_bb0375","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(04)17183-3","article-title":"A difficult diagnosis","volume":"364","author":"Cohen Tervaert","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.autrev.2025.103924_bb0380","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/ph16060846","article-title":"Pulmonary-renal syndrome from levamisole-adulterated cocaine-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a systematic review","volume":"16","author":"Bucur","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"7","key":"10.1016\/j.autrev.2025.103924_bb0385","first-page":"625","article-title":"Etiology and precipitating factors of necrotizing angiitis with respiratory manifestations. 5 case reports","volume":"134","author":"Guillevin","year":"1983","journal-title":"Ann Med Interne (Paris)"},{"issue":"10","key":"10.1016\/j.autrev.2025.103924_bb0390","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1093\/ndt\/gfp398","article-title":"Influenza vaccination in ANCA-associated vasculitis","volume":"24","author":"Spaetgens","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.autrev.2025.103924_bb0395","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/ndt\/gfm640","article-title":"Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis","volume":"23","author":"Stassen","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.autrev.2025.103924_bb0400","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/nep.12416","article-title":"Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"20","author":"Jeffs","year":"2015","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"10.1016\/j.autrev.2025.103924_bb0405","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/ard.57.4.256","article-title":"A case of Churg-Strauss vasculitis after hepatitis B vaccination","volume":"57","author":"Vanoli","year":"1998","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2025.103924_bb0410","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/1319-2442.225178","article-title":"A case of renal granulomatosis with polyangiitis following intravesical bacillus Calmette-Gu\u00e9rin therapy","volume":"29","author":"Selmi","year":"2018","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"2","key":"10.1016\/j.autrev.2025.103924_bb0415","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4103\/jcrt.JCRT_890_20","article-title":"Bacillus Calmette-Gu\u00e9rin-induced perinuclear antineutrophil cytoplasmic antibodies associated vasculitis in bladder cancer","volume":"17","author":"Kocak","year":"2021","journal-title":"J Cancer Res Ther"},{"issue":"8","key":"10.1016\/j.autrev.2025.103924_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104847","article-title":"Increased induction of de novo serum ANCA and ANCA-associated vasculitis after mass vaccination against SARS-CoV-2","volume":"25","author":"Irure-Ventura","year":"2022","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.autrev.2025.103924_bb0425","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.autrev.2025.103924_bb0430","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/vaccines9040321","article-title":"Adjuvants and vaccines used in allergen-specific immunotherapy induce neutrophil extracellular traps","volume":"9","author":"Karacs","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.autrev.2025.103924_bb0435","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32946-1","article-title":"NETosis and thrombosis in vaccine-induced immune thrombotic thrombocytopenia","volume":"13","author":"Leung","year":"2022","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.autrev.2025.103924_bb0440","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/cmi.2017.151","article-title":"Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction","volume":"15","author":"Segal","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2025.103924_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103070","article-title":"Molecular mimicry and autoimmunity in the time of COVID-19","volume":"139","author":"Rojas","year":"2023","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2025.103924_bb0450","series-title":"Infection and Autoimmunity","first-page":"43","article-title":"Molecular mimicry study between peptides of SARS-CoV-2 and neutrophil extracellular traps-related proteins","author":"Adiguzel","year":"2024"},{"key":"10.1016\/j.autrev.2025.103924_bb0455","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.phrs.2015.08.003","article-title":"Vaccines, adjuvants and autoimmunity","volume":"100","author":"Guimar\u00e3es","year":"2015","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.autrev.2025.103924_bb0460","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/1756-185X.14238","article-title":"COVID-19 vaccination can occasionally trigger autoimmune phenomena, probably via inducing age-associated B cells","volume":"25","author":"Sachinidis","year":"2022","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2025.103924_bb0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177365","article-title":"Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant","volume":"12","author":"van Aalst","year":"2017","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.autrev.2025.103924_bb0470","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00002281-199901000-00005","article-title":"The role of superantigens in vasculitis","volume":"11","author":"Tervaert","year":"1999","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2025.103924_bb0475","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2169\/internalmedicine.42.771","article-title":"The relation between Staphylococcus aureus and Wegener\u2019s granulomatosis: current knowledge and future directions","volume":"42","author":"Popa","year":"2003","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.autrev.2025.103924_bb0480","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s42003-024-07350-8","article-title":"The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory properties on T-cells","volume":"8","author":"Tu","year":"2025","journal-title":"Commun Biol"},{"key":"10.1016\/j.autrev.2025.103924_bb0485","first-page":"52","article-title":"Significance of the SARS-CoV-2 spike protein \u2018Superantigen\u2019 sequence in the mRNA vaccines","volume":"2","author":"Hatfill","year":"2022","journal-title":"J Am Phys Surg"},{"issue":"3","key":"10.1016\/j.autrev.2025.103924_bb0490","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/cei\/uxad043","article-title":"New insights of antineutrophil cytoplasmic antibody-associated vasculitis from the perspective of COVID-19 vaccination","volume":"213","author":"Yang","year":"2023","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2025.103924_bb0495","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/ckj\/sfac186","article-title":"ANCA-associated vasculitis flare might be provoked by COVID-19 infection: a case report and a review of the literature","volume":"15","author":"Ozcan","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.autrev.2025.103924_bb0500","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1301492","article-title":"Understanding COVID-19 vaccine hesitancy in vasculitis patients","volume":"11","author":"Butt","year":"2023","journal-title":"Front Public Health"},{"issue":"23","key":"10.1016\/j.autrev.2025.103924_bb0505","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1097\/CM9.0000000000000539","article-title":"Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"132","author":"Weng","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.autrev.2025.103924_bb0510","series-title":"Oxford Textbook of Vasculitis","article-title":"Drug-induced vasculitis","author":"Cohen Tervaert","year":"2025"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225001855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225001855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T13:05:59Z","timestamp":1767099959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225001855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1568997225001855"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103924","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug- and vaccine induced ANCA-associated vasculitis: An overview","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103924"}}